APOA1 and Huntington disease: Lp(a) is strongly and negatively associated with apoA isoform size (Marcovina et al. 1995) and is elevated in HD patients (Kronenberg et al. 1995), suggesting that Lp(a) level or small apoA may account for a portion of the increased atherosclerotic CVD or mortality in ESRD patients.